Susquehanna International Group’s Ascendis Pharma ASND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-11,395
Closed -$1.78M 6372
2025
Q1
$1.78M Sell
11,395
-18,465
-62% -$2.88M ﹤0.01% 2448
2024
Q4
$4.11M Buy
29,860
+27,854
+1,389% +$3.83M ﹤0.01% 1230
2024
Q3
$300K Sell
2,006
-4,307
-68% -$643K ﹤0.01% 4302
2024
Q2
$861K Buy
+6,313
New +$861K ﹤0.01% 2755
2024
Q1
Hold
0
5545
2023
Q4
Sell
-19,330
Closed -$1.81M 5920
2023
Q3
$1.81M Buy
19,330
+4,696
+32% +$440K ﹤0.01% 1925
2023
Q2
$1.31M Buy
+14,634
New +$1.31M ﹤0.01% 2390
2023
Q1
Sell
-7,081
Closed -$865K 5971
2022
Q4
$865K Sell
7,081
-38,381
-84% -$4.69M ﹤0.01% 2495
2022
Q3
$4.69M Buy
+45,462
New +$4.69M ﹤0.01% 897
2022
Q2
Sell
-36,587
Closed -$4.29M 5775
2022
Q1
$4.29M Buy
36,587
+10,092
+38% +$1.18M ﹤0.01% 1280
2021
Q4
$3.56M Buy
26,495
+19,920
+303% +$2.68M ﹤0.01% 1460
2021
Q3
$1.05M Sell
6,575
-15,043
-70% -$2.4M ﹤0.01% 2699
2021
Q2
$2.84M Buy
21,618
+12,592
+140% +$1.66M ﹤0.01% 1739
2021
Q1
$1.16M Sell
9,026
-7,508
-45% -$967K ﹤0.01% 2792
2020
Q4
$2.76M Sell
16,534
-5,373
-25% -$896K ﹤0.01% 1454
2020
Q3
$3.38M Buy
21,907
+18,520
+547% +$2.86M ﹤0.01% 1052
2020
Q2
$501K Buy
3,387
+199
+6% +$29.4K ﹤0.01% 2920
2020
Q1
$359K Sell
3,188
-174,973
-98% -$19.7M ﹤0.01% 3245
2019
Q4
$24.8M Sell
178,161
-4,562
-2% -$635K 0.01% 251
2019
Q3
$17.6M Buy
182,723
+108,876
+147% +$10.5M 0.01% 266
2019
Q2
$8.5M Buy
+73,847
New +$8.5M ﹤0.01% 450
2019
Q1
Hold
0
3043
2018
Q4
Sell
-132,442
Closed -$9.39M 3660
2018
Q3
$9.39M Sell
132,442
-85,103
-39% -$6.03M ﹤0.01% 381
2018
Q2
$14.5M Buy
+217,545
New +$14.5M 0.01% 292